You can defuse the threat of severe consequences like cirrhosis for patients
with MASH with significant fibrosis (F2/F3), a disease that can progress rapidly.^1,2

Uncover the consequences

Fibrosis progression can be rapid and unpredictable, and is fueled by dysfunction in the liver.^1-3

Explore the dangers

MASH with significant fibrosis requires timely and proactive management.¹

Defuse the threat

Managing MASH with significant fibrosis requires addressing the underlying dysfunction in critical liver processes^3,4

See a management option

MASH=metabolic dysfunction-associated steatohepatitis.

References: 1. Rinella ME et al. Hepatology. 2023;77(5):1797-1835. 2. Singh S et al. Clin Gastroenterol Hepatol. 2015;13(4):643-654. 3. Karim G, Bansal MB. touchREV Endocrinol. 2023;19(1):60-70. 4. Zeng J et al. United European Gastroenterol J. 2024;12(2):177-186.

You can defuse the threat of severe consequences like cirrhosis for patients with MASH with significant fibrosis (F2/F3), a disease that can progress rapidly.1,2

Managing MASH with significant fibrosis requires addressing the underlying dysfunction in critical liver processes3,4

You can defuse the threat of severe consequences like cirrhosis for patients
with MASH with significant fibrosis (F2/F3), a disease that can progress rapidly.^1,2

Managing MASH with significant fibrosis requires addressing the underlying dysfunction in critical liver processes^3,4